Kris Jenner, M.D., D. PHIL., was most recently a vice president of T. Rowe Price Group, Inc., and T. Rowe Price Associates, Inc. He was also a portfolio manager and research analyst in the U.S. Equity Division specializing in the coverage of U.S. pharmaceutical and biotechnology companies under the healthcare industry. Jenner was president of the Health Sciences Fund and was chairman of the fund's Investment Advisory Committee. He was also a vice president and Investment Advisory Committee member of the Blue Chip Growth Fund, Growth Stock Fund, Mid-Cap Growth Fund, New Horizons Fund and T. Rowe Price International Funds, Inc. (Global Stock Fund). Kris joined the firm in 1997 with five years of previous investment experience. Prior to going to T. Rowe Price, he worked at the Laboratory of Biological Cancer, The Brigham & Women's Hospital, Harvard Medical School. He earned a B.S. in chemistry, summa cum laude, from the University of Illinois, a D. Phil. from Oxford University, and an M.D. from the Johns Hopkins University, School of Medicine. Jenner completed two years of a general surgery residency at the Johns Hopkins Hospital.